Ameritas Advisory Services LLC bought a new position in shares of VanEck Biotech ETF (NASDAQ:BBH – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 371 shares of the company’s stock, valued at approximately $57,000.
Several other institutional investors also recently made changes to their positions in BBH. Simplex Trading LLC raised its position in shares of VanEck Biotech ETF by 100.8% in the 1st quarter. Simplex Trading LLC now owns 474 shares of the company’s stock worth $74,000 after buying an additional 238 shares during the period. SVB Wealth LLC acquired a new position in VanEck Biotech ETF in the first quarter valued at $90,000. Strategic Financial Services Inc. acquired a new position in VanEck Biotech ETF in the first quarter valued at $203,000. Continuum Advisory LLC boosted its holdings in VanEck Biotech ETF by 26.1% in the first quarter. Continuum Advisory LLC now owns 1,304 shares of the company’s stock valued at $205,000 after acquiring an additional 270 shares during the last quarter. Finally, Flagship Harbor Advisors LLC boosted its holdings in VanEck Biotech ETF by 9.8% in the first quarter. Flagship Harbor Advisors LLC now owns 2,179 shares of the company’s stock valued at $343,000 after acquiring an additional 195 shares during the last quarter. 32.05% of the stock is owned by hedge funds and other institutional investors.
VanEck Biotech ETF Trading Down 1.5%
Shares of VanEck Biotech ETF stock opened at $172.13 on Monday. VanEck Biotech ETF has a twelve month low of $135.34 and a twelve month high of $178.95. The business’s fifty day moving average price is $166.39 and its 200 day moving average price is $156.85.
About VanEck Biotech ETF
The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.
Read More
- Five stocks we like better than VanEck Biotech ETF
- How to Invest in Blue Chip Stocks
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- What is an Earnings Surprise?
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Stock Average Calculator
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding BBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Biotech ETF (NASDAQ:BBH – Free Report).
Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.